Is 1,8-Cineole-Rich Extract of Small Cardamom Seeds More Effective in Preventing Alzheimer’s Disease than 1,8-Cineole Alone?

[1]  P. Barbarino,et al.  THE STATE OF THE ART OF DEMENTIA RESEARCH: NEW FRONTIERS , 2019, Alzheimer's & Dementia.

[2]  R. Cappai,et al.  Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson’s Disease , 2019, Neurotoxicity Research.

[3]  S. Chakrabarti,et al.  Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements , 2019, Journal of Chemical Neuroanatomy.

[4]  D. Holtzman,et al.  New insights into the role of TREM2 in Alzheimer’s disease , 2018, Molecular Neurodegeneration.

[5]  Bryan Maloney,et al.  Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease , 2018, Molecular Psychiatry.

[6]  K. Blennow,et al.  Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase , 2018, Molecular Neurodegeneration.

[7]  Seema Patel,et al.  An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent , 2018, Oxidative medicine and cellular longevity.

[8]  P. Bhattacharjee,et al.  Process Optimization of Supercritical Carbon Dioxide Extraction of 1,8-Cineole from Small Cardamom Seeds by Response Surface Methodology: In Vitro Antioxidant, Antidiabetic and Hypocholesterolemic Activities of Extracts , 2018 .

[9]  A. Romano,et al.  Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence , 2018, Oxidative medicine and cellular longevity.

[10]  Min-Suk Kim,et al.  Effect of natural antioxidants on the aggregation and disaggregation of beta-amyloid , 2018 .

[11]  S. Habtemariam.  Iridoids and Other Monoterpenes in the Alzheimer’s Brain: Recent Development and Future Prospects , 2018, Molecules.

[12]  S. Ibrahim,et al.  Comparative Study between Direct and Pseudomorphic Transformation of Rice Husk Ash into MFI-Type Zeolite , 2017, Molecules.

[13]  L. Saso,et al.  Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease , 2017, Drug design, development and therapy.

[14]  I. Menezes,et al.  Repeated-doses and reproductive toxicity studies of the monoterpene 1,8-cineole (eucalyptol) in Wistar rats. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  J. Cummings,et al.  Alzheimer's drug-development pipeline: 2016 , 2016, Alzheimer's & dementia.

[16]  G. Cardona-Gómez,et al.  Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice , 2016, Neuropharmacology.

[17]  P. Bhattacharjee,et al.  1,8-cineol-rich Cardamom Seed (Elettaria cardamomum) Extracts Using Green Technologies and Conventional Extractions: Process Analysis, Phytochemical Characterization, and Food Application , 2015 .

[18]  Jeff H Duyn,et al.  The role of iron in brain ageing and neurodegenerative disorders , 2014, The Lancet Neurology.

[19]  L. Saso,et al.  Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein , 2014, NeuroMolecular Medicine.

[20]  Zhichun Chen,et al.  Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies , 2013, Progress in Neurobiology.

[21]  A. Mitra,et al.  Flavoring Extracts of Hemidesmus indicus Roots and Vanilla planifolia Pods Exhibit In vitro Acetylcholinesterase Inhibitory Activities , 2013, Plant Foods for Human Nutrition.

[22]  F. Barile.  Toxicogenomics and epigenetic testing in vitro , 2013 .

[23]  Frank A. Barile,et al.  Principles of Toxicology Testing, Second Edition , 2013 .

[24]  A. Banerjee,et al.  Antioxidant role of amyloid β protein in cell-free and biological systems: implication for the pathogenesis of Alzheimer disease. , 2013, Free radical biology & medicine.

[25]  Sokratis G. Papageorgiou,et al.  Current and future treatments for Alzheimer’s disease , 2013, Therapeutic advances in neurological disorders.

[26]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[27]  C. Reitz.  Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review , 2012, International journal of Alzheimer's disease.

[28]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[29]  Fabio Biscarini,et al.  Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. , 2011, Analytical biochemistry.

[30]  S. Jana,et al.  Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease. , 2011, Biochimica et biophysica acta.

[31]  Daniela Galimberti,et al.  Disease-modifying treatments for Alzheimer’s disease , 2011, Therapeutic advances in neurological disorders.

[32]  P. Schieberle,et al.  Characterization of alpha-terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. , 2007, Journal of agricultural and food chemistry.

[33]  R. Swerdlow,et al.  Pathogenesis of Alzheimer’s disease , 2007, Clinical interventions in aging.

[34]  M. Hermes-Lima.  Oxygen in Biology and Biochemistry: Role of Free Radicals , 2005 .

[35]  G. Johnson,et al.  Tau phosphorylation: physiological and pathological consequences. , 2005, Biochimica et biophysica acta.

[36]  S. Chakrabarti,et al.  Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate , 2001, Neurochemistry International.

[37]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[38]  F. Küçükbay,et al.  Essential Oil Composition of Elettaria cardamomum Maton , 2013 .

[39]  L. Tan,et al.  Novel disease-modifying therapies for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[40]  S. Mandel,et al.  From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[41]  T. Wyss-Coray,et al.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. , 2012, Cold Spring Harbor perspectives in medicine.

[42]  M. Obulesu,et al.  Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues , 2011, Journal of neurosciences in rural practice.

[43]  V. Schulz.  Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.